Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in PRLD — Prelude Therapeutics Inc

CIK 1446194 BALA CYNWYD, PA
Back to PRLD Full portfolio

Position in PRLD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$915,834 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
14 quarters on record

Common Shares in PRLD Over Time

Shares Held

Position Value (USD)

Derivatives in PRLD

reported options exposure · as of Jun 30, 2026
CallValue
$591,630
CallShares
111,000
PutValue
$339,521
PutShares
63,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in PRLD

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $339,521 63,700
2026-06-30 $591,630 111,000
2026-03-31 $71,820 21,000
2026-03-31 $915,834 267,788
2025-12-31 $394,136 135,909
2025-12-31 $94,250 32,500
2025-06-30 $32,341 39,977
2025-03-31 $59,804 77,870
2024-12-31 $92,818 72,799
2023-03-31 $739,176 129,680
2022-12-31 $563,471 93,290
2022-09-30 $535,410 81,000
2022-09-30 $89,836 13,591
2022-06-30 $153,614 29,428
2022-06-30 $555,930 106,500
2022-03-31 $276,000 40,000
2021-12-31 $364,473 29,275
2021-09-30 $613,437 19,630
2021-06-30 $491,090 17,153